NFKB1 and viral infectious disease: Furthermore, in order to exclude that NF-κB inhibition is only a consequence of a reduced viral infection in these SARS-CoV-2-infected cells, pretreated with compound PI-7, we have also tested the phosphorylation of p65 in non-infected human primary nasal cells with PI-7 for 24 h (Fig. EV5C).